Department of Otorhinolaryngology, Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi, 435000, Hubei, China.
Department of Anesthesiology, Huangshi Maternity and Children's Health Hospital, 9 Guilin South Road, Xialu District, Huangshi, 435000, Hubei, China.
J Mol Histol. 2021 Jun;52(3):577-587. doi: 10.1007/s10735-021-09969-x. Epub 2021 Mar 26.
Long non-coding RNAs (LncRNAs) have gained widespread interest and attention as vital regulators in cancer occurrence and development. Nonetheless, the functions and mechanisms of lncRNAs involved in nasopharyngeal carcinoma (NPC) are largely unknown. By analysing the data from GSE61218, we identified a novel lncRNA LINC01515 which is altered in NPC. A series of experiments were performed to examine the exact roles of LINC01515 as well as the molecular mechanisms by which LINC01515 acted in NPC. LINC01515 expression was increased in NPC and that high LINC01515 expression was associated with a worse prognosis. Functionally, depletion of LINC01515 resulted in an inhibition of cell proliferation, migration and invasion, while apoptosis was promoted. Mechanistically, LINC01515 facilitated cell division cycle associated 5 (CDCA5) expression via serving as a sponge for miR-325. And more notably, miR-325 suppressed NPC progression in vitro by targeting CDCA5. Furthermore, the anti-tumor property induced by LINC01515 knockdown was partially reversed due to the overexpression of CDCA5. Taken together, LINC01515 exerted the carcinogenic effect in NPC through regulating miR-325/CDCA5 pathway. Our findings shed light on the possibility of exploiting LINC01515 as a prognostic biomarker or therapeutic target in NPC.
长链非编码 RNA(lncRNAs)作为癌症发生和发展的重要调节因子,引起了广泛的关注和重视。然而,lncRNAs 在鼻咽癌(NPC)中的功能和机制在很大程度上尚不清楚。通过分析 GSE61218 中的数据,我们鉴定出一种新型的 lncRNA LINC01515,其在 NPC 中发生改变。进行了一系列实验来研究 LINC01515 的确切作用以及 LINC01515 在 NPC 中作用的分子机制。结果显示,LINC01515 在 NPC 中表达增加,并且高表达与预后不良相关。功能上,LINC01515 的耗竭导致细胞增殖、迁移和侵袭受到抑制,而促进了细胞凋亡。机制上,LINC01515 通过作为 miR-325 的海绵来促进细胞分裂周期相关蛋白 5(CDCA5)的表达。更值得注意的是,miR-325 通过靶向 CDCA5 抑制 NPC 体外进展。此外,由于 CDCA5 的过表达,LINC01515 敲低引起的抗肿瘤特性部分逆转。综上所述,LINC01515 通过调节 miR-325/CDCA5 通路在 NPC 中发挥致癌作用。我们的研究结果表明,LINC01515 有可能成为 NPC 的预后标志物或治疗靶点。